AHRQ’s Role in Meeting the American Indian/Alaska Native Trust Responsibility
Peter B. Angood, M.D.
Related Articles
Diagnosis and Management of Obsessive Compulsive Disorders in Children
This review focuses on the diagnostic accuracy of brief OCD assessment tools and the treatment of OCD in children. The 2012 American Academy of Child…
Ensuring Adequate Nurse Staffing in a Public Health Emergency
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
ASHP Midyear: Elevated Lp(a) Levels Pose Significant Cardiovascular Risk, Experts Emphasize Need for Awareness
Lp(a) is a critical risk factor for atherosclerotic cardiovascular disease, but current lipid-lowering therapies are largely ineffective at lowering Lp(a) levels.
Equity Means Everybody – NCQA
Health equity has long been a principle of quality health care.But health equity has faced resistance in 2024, including at the ballot box. What does…
National Action Alliance for Patient and Workforce Safety Webinar
National Action Alliance for Patient and Workforce Safety Webinar announcement
Ensuring Adequate Nurse Staffing in a Public Health Emergency
Karen Blanchette Lasater, Ph.D., R.N., FAANAssociate Professor of NursingUniversity of Pennsylvania
ICYMI: Highlights From ACCC Fall 2024
Top content from the Association of Cancer Care Centers (ACCC) fall conference included topics on patient participation, new cancer care programs, prior authorization processing, and…
Surveys on Patient Safety Culture for New Users
.yellow { background-color: #FDB81E; color: #323A45; } .yellow:hover { background-color: #FFF1D2; color: #323A45; }
ASH 2024: Zanubrutinib Monotherapy, With Obinutuzimab Demonstrates Durable Efficacy and Safety in CLL/SLL
Constantine Tam, MD, discusses zanubrutinib’s efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.